Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Localized Extraskeletal Ewing Sarcoma × Razoxane × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 PRETEXT I Hepatoblastoma 1 Neuroblastoma 1 Localized Extraskeletal Ewing Sarcoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1 Ganglioneuroblastoma 1 Burkitt Lymphoma 1

Interventions

Vincristine 1 Topotecan 1 Razoxane 1 Ifosfamide 1 Etoposide 1 Doxorubicin 1 Dexrazoxane 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01231906 2026-01-23

Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma

Children's Oncology Group

Phase 3 Completed

642 enrolled 11 charts

Localized Extraskeletal Ewing Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡